İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2018

Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

Hematology (Amsterdam, Netherlands)

YÖKSİS OpenAlex Açık erişim · gold SJR Q3 JCR Q4 Atıf 11 Yüzdelik 83.7% FWCI 1.54
Yıl
2018
ISSN
1024-5332
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

Statement of RetractionThe following article has been retracted from publication in the Taylor & Francis journal Hematology:Guray Saydam, Ibrahim C. Haznedaroglu, Leylagul Kaynar, Akif S. Yavuz, Ridvan Ali, Birol Guvenc, Olga M. Akay, Zafer Baslar, Ugur Ozbek, Mehmet Sonmez, Demet Aydin, Mustafa Pehlivan, Bulent Undar, Simten Dagdas, Orhan Ayyildiz, Diyar Z. Akkaynak, Gulnur Akin & Osman İlhan, Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, Hematology, https://doi.org/10.1080/10245332.2018.1444919. Version of Record published online 27 February 2018.The above article is being retracted as it it has been brought to the attention of the Editor and Managing Editor of Hematology that it was previously published as: Guray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, Akif S. Yavuz, Ridvan Ali, Birol Guvenc, Olga M. Akay, Zafer Baslar, Ugur Ozbek, Mehmet Sonmez, Demet Aydin, Mustafa Pehlivan, Bulent Undar, Simten Dagdas, Orhan Ayyildiz, Diyar Z. Akkaynak, Ilkiz M. Dag & Osman Ilhan “Outcomes With Frontline Nilotinib Treatment in Turkish Patients With Newly Diagnosed Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase” Expert Opinion on Pharmacotherapy, volume 17, issue 14, pages 1851-1858, doi: https://doi.org/10.1080/14656566.2016.1219338. The authors had intended to submit a follow-up article to Hematology but inadvertently submitted the same manuscript. The authors have agreed to the publication of this notice.© Taylor & Francis

Konular

  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research

Birincil konu Chronic Myeloid Leukemia Treatments

Yazarlar

  1. GÜRAY SAYDAM EGE ÜNİVERSİTESİ
  2. LEYLAGÜL KAYNAR İSTANBUL MEDİPOL ÜNİVERSİTESİ
  3. RIDVAN ALİ
  4. BİROL GÜVENÇ ÇUKUROVA ÜNİVERSİTESİ
  5. ZAFER BAŞLAR
  6. UĞUR ÖZBEK
  7. OSMAN İLHAN LOKMAN HEKİM ÜNİVERSİTESİ